Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02366689 · ClinicalTrials.gov registry record · Phase 4
Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash)
A Phase 4 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 4
- Development phase
- 179
- Enrollment target
NCT02366689: Completed Phase 4 study, sponsored by Colgate Palmolive.
NCT02366689 is a Phase 4 study that has completed, run by Colgate Palmolive. The registered enrollment target is 179 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02366689, a Phase 4 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 179 participants
- Enrollment target
Study Summary
The objective of this clinical research study is to assess the efficacy of a commercially available triclosan/copolymer toothpaste compared to a commercially available oral hygiene multi-component regimen encompassing the use of a manual toothbrush, a toothpaste containing stannous fluoride / sodium hexametaphosphate and a mouthwash containing cetylpyridinium chloride relative to a negative control regimen in reducing established dental plaque and gingivitis over three and six months of assigned product use.
Primary Outcome
Dental Plaque (Quigley-Hein, Turesky Modification Index) Units on a scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque, 3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
Interventions
- DRUG stannous fluoride toothpaste
- DRUG Triclosan/fluoride toothpaste
- DRUG fluoride only toothpaste
- DRUG Cetylpyridinium chloride mouthwash
- DRUG Fluoride only mouthwash
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 179 participants |
| Start Date | 2014-06 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
What the finished NCT02366689 record still lists
NCT02366689 is an interventional study that assigns participants to a tested intervention. The registered 179 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 5 interventions - of which stannous fluoride toothpaste is the first listed.
NCT02366689 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02366689 about?
NCT02366689 is a clinical study titled "Clinical Study Comparing Dental Plaque and Gingivitis Reduction After Using One of Three Oral Hygiene Multi-component Regimens (Using of a Manual Toothbrush, a Toothpaste and a Mouthwash)". The objective of this clinical research study is to assess the efficacy of a commercially available triclosan/copolymer toothpaste compared to a commercially available oral hygiene multi-component regimen encompassing the use of a manual toothbrush, a toothpaste containing stannous fluoride / sodium...
What is the current status of trial NCT02366689?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 179 participants. The study started on 2014-06. Estimated completion is 2014-12.
What interventions are being tested in trial NCT02366689?
The interventions under investigation include: stannous fluoride toothpaste (DRUG), Triclosan/fluoride toothpaste (DRUG), fluoride only toothpaste (DRUG), Cetylpyridinium chloride mouthwash (DRUG), Fluoride only mouthwash (DRUG).
Who is sponsoring clinical trial NCT02366689?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02366689's enrollment target sits among peer trials
179 476th of 2000 higher than 1,524 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06581198 · 179 participants · Phase 2
A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
- NCT07356323 · 179 participants · NA
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia